TuHURA Historical Financial Ratios
| HURA Stock | 4.93 0.45 8.36% |
TuHURA Biosciences is promptly reporting on over 70 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 or Invested Capital of 0.0 will help investors to properly organize and evaluate TuHURA Biosciences financial condition quickly.
TuHURA |
About TuHURA Financial Ratios Analysis
TuHURA BiosciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate TuHURA Biosciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on TuHURA financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across TuHURA Biosciences history.
TuHURA Biosciences Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing TuHURA Biosciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on TuHURA Biosciences sales, a figure that is much harder to manipulate than other TuHURA Biosciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to TuHURA Biosciences. There are two different methods for calculating TuHURA Biosciences invested capital: operating approach and financing approach. Understanding TuHURA Biosciences invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Most ratios from TuHURA Biosciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into TuHURA Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.At present, TuHURA Biosciences' Days Payables Outstanding is projected to increase significantly based on the last few years of reporting. The current year's ROE is expected to grow to 19.75, whereas Dividend Yield is forecasted to decline to 0.000003.
| 2023 | 2024 (projected) | Net Debt To EBITDA | 0.0453 | 0.0431 | Intangibles To Total Assets | 0.003436 | 0.004885 |
TuHURA Biosciences fundamentals Correlations
Click cells to compare fundamentals
TuHURA Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
TuHURA Biosciences fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 956.24 | 194.36 | (1.8M) | 31.75 | (8.5K) | (8.9K) | |
| Book Value Per Share | 44.07 | 715.37 | (0.0178) | 265.83 | (0.0229) | (0.0218) | |
| Free Cash Flow Yield | (0.0315) | (0.009175) | (5.0E-6) | (0.0193) | (9.07E-4) | (9.53E-4) | |
| Operating Cash Flow Per Share | (4.3K) | (1.3K) | (1.3K) | (0.16) | (162.22) | (0.18) | |
| Pb Ratio | 956.24 | 194.36 | (1.8M) | 31.75 | (8.5K) | (8.9K) | |
| Free Cash Flow Per Share | (1.3K) | (1.3K) | (0.16) | (163.0) | (0.18) | (0.19) | |
| Roic | (30.97) | (2.04) | 69.93 | (0.81) | (38.89) | (36.94) | |
| Net Income Per Share | (1.5K) | (2.6K) | (0.17) | (202.39) | (0.43) | (0.45) | |
| Cash Per Share | 400.8 | 712.39 | 0.13 | 307.93 | 0.0539 | 0.0512 | |
| Pocfratio | (31.72) | (109.04) | (200.0K) | (52.03) | (1.1K) | (1.2K) | |
| Payout Ratio | (7.5E-4) | (0.001038) | (8.77E-4) | (2.09E-4) | (1.88E-4) | (1.97E-4) | |
| Pfcf Ratio | (31.72) | (108.99) | (199.9K) | (51.78) | (1.1K) | (1.2K) | |
| Days Payables Outstanding | 22.0K | 38.9K | 73.4K | 25.3K | 22.8K | 28.0K | |
| Income Quality | 0.87 | 0.49 | 0.94 | 0.8 | 0.41 | 0.39 | |
| Roe | (34.7) | (3.62) | 9.38 | (0.76) | 18.81 | 19.75 | |
| Ev To Operating Cash Flow | (31.42) | (108.48) | (200.0K) | (50.15) | (1.1K) | (1.2K) | |
| Pe Ratio | (27.56) | (53.7) | (187.1K) | (41.7) | (452.28) | (474.89) | |
| Return On Tangible Assets | (3.11) | (2.83) | (1.1) | (0.62) | (6.72) | (6.39) | |
| Ev To Free Cash Flow | (31.42) | (108.44) | (199.9K) | (49.91) | (1.1K) | (1.2K) | |
| Earnings Yield | (0.0363) | (0.0186) | (5.0E-6) | (0.024) | (0.002211) | (0.002322) | |
| Net Debt To E B I T D A | 0.46 | 0.26 | 0.28 | 1.48 | 0.0453 | 0.0431 | |
| Current Ratio | 1.03 | 4.24 | 0.79 | 5.13 | 1.16 | 1.1 | |
| Tangible Book Value Per Share | 44.07 | 715.37 | (0.0178) | 265.83 | (0.0229) | (0.0218) | |
| Graham Number | 1.2K | 6.5K | 0.26 | 1.1K | 0.47 | 0.45 | |
| Shareholders Equity Per Share | 44.07 | 715.37 | (0.0178) | 265.83 | (0.0229) | (0.0218) | |
| Graham Net Net | (47.42) | 512.14 | (0.0382) | 245.43 | (0.0332) | (0.0315) | |
| Enterprise Value Over E B I T D A | (27.33) | (53.64) | (218.6K) | (39.38) | (455.28) | (478.04) | |
| Price Earnings Ratio | (27.56) | (53.7) | (187.1K) | (41.7) | (452.28) | (474.89) | |
| Price Book Value Ratio | 956.24 | 194.36 | (1.8M) | 31.75 | (8.5K) | (8.9K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.